¼¼°èÀÇ ¿ïÇ÷¼º ½ÉºÎÀü ½ÃÀå : À¯Çüº°, Áø´Üº°, ¼ºº°, ¿¬·ÉÃþº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Congestive Heart Failure Market, By Type, By Diagnosis, By Gender, By Age Group, By End User, By Geography
»óǰÄÚµå : 1747498
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,151,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,569,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,671,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¿ïÇ÷¼º ½ÉºÎÀü ½ÃÀåÀº 2025³â¿¡ 249¾ï 5,000¸¸ ´Þ·¯, 2032³â¿¡´Â 408¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 7.3%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 249¾ï 5,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 7.30% 2032³â °¡Ä¡ ¿¹Ãø 408¾ï 5,000¸¸ ´Þ·¯

¼¼°è ¿ïÇ÷¼º ½ÉºÎÀü ½ÃÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, È¿°úÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀ¸·Î ÀÎÇØ ÃÖ±Ù ¸î ³â µ¿¾È °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¿ïÇ÷¼º ½ÉºÎÀü(CHF)Àº ½ÉÀåÀÌ ½Åü¿¡ ÇÊ¿äÇÑ Ç÷¾×À» ÃæºÐÈ÷ °ø±ÞÇÏÁö ¸øÇÏ´Â ¸¸¼º ÁúȯÀÔ´Ï´Ù. ÷´Ü Áø´Ü ±â¼ú°ú Çõ½ÅÀûÀÎ Ä¡·á¹ýÀÇ µîÀåÀ¸·Î CHF °ü¸® ½ÃÀåÀº Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:.

¼¼°è ¿ïÇ÷¼º ½ÉºÎÀü ½ÃÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÁÂ½Ä »ýȰ½À°ü Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ïÇ÷¼º ½ÉºÎÀüÀÇ Á¶±â Áø´Ü ¹× Ä¡·áÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÀϺΠÁö¿ª¿¡¼­´Â ³ôÀº Ä¡·á ºñ¿ë°ú ºÒÃæºÐÇÑ »óȯ Á¤Ã¥À¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ç¿ë °¡´ÉÇÑ ÀϺΠġ·á ¿É¼Ç°ú °ü·ÃµÈ ºÎÀÛ¿ëµµ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹Ý¸é, À¯ÀüÀÚ Ä¡·á, Áٱ⼼Æ÷ Ä¡·á¿Í °°Àº »õ·Î¿î Ä¡·á¹ý °³¹ß°ú °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå Âü¿©Àڵ鿡°Ô Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ½Å±Ô Ä¡·áÁ¦ °³¹ßÀ» À§ÇÑ Á¦¾à±â¾÷°ú ¿¬±¸±â°üÀÇ °øµ¿¿¬±¸ Áõ°¡µµ ÇâÈÄ ¸î ³â°£ ½ÃÀå °³Ã´À» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¿ïÇ÷¼º ½ÉºÎÀü ½ÃÀå, À¯Çüº°, 2020³â-2032³â

Á¦5Àå ¼¼°èÀÇ ¿ïÇ÷¼º ½ÉºÎÀü ½ÃÀå, Áø´Üº°, 2020³â-2032³â

Á¦6Àå ¼¼°èÀÇ ¿ïÇ÷¼º ½ÉºÎÀü ½ÃÀå, µð¹ÙÀ̽º À¯Çüº°, 2020³â-2032³â

Á¦7Àå ¼¼°èÀÇ ¿ïÇ÷¼º ½ÉºÎÀü ½ÃÀå, ¼ºº°, 2020³â-2032³â

Á¦8Àå ¼¼°èÀÇ ¿ïÇ÷¼º ½ÉºÎÀü ½ÃÀå, ¿¬·ÉÃþº°, 2020³â-2032³â

Á¦9Àå ¼¼°èÀÇ ¿ïÇ÷¼º ½ÉºÎÀü ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020³â-2032³â

Á¦10Àå ¼¼°èÀÇ ¿ïÇ÷¼º ½ÉºÎÀü ½ÃÀå, Áö¿ªº°, 2020³â-2032³â

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

Á¦13Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Congestive Heart Failure Market is estimated to be valued at USD 24.95 Bn in 2025 and is expected to reach USD 40.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 24.95 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.30% 2032 Value Projection: USD 40.85 Bn

The global congestive heart failure market has witnessed significant growth in recent years, driven by the increasing prevalence of cardiovascular diseases, the rising geriatric population, and the growing demand for effective treatment options. Congestive heart failure (CHF) is a chronic condition characterized by the heart's inability to pump sufficient blood to meet the body's needs. With the advent of advanced diagnostic techniques and innovative treatment approaches, the market for CHF management has expanded considerably.

Market Dynamic:

The global congestive heart failure market is driven by several factors, including the rising prevalence of cardiovascular diseases, the growing geriatric population, and the increasing adoption of sedentary lifestyles. The increasing awareness about the importance of early diagnosis and treatment of CHF have also contributed to the market growth. However, the high cost of treatment and the lack of reimbursement policies in some regions may restrain the market growth. Moreover, the side effects associated with some of the available treatment options may also hinder the market growth. On the other hand, the development of novel therapies, such as gene therapy and stem cell therapy, and the increasing focus on personalized medicine offer significant growth opportunities for the market players. Increasing collaborations between pharmaceutical companies and research institutes for the development of novel therapies are also expected to drive the market growth in the coming years.

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Congestive Heart Failure Market, By Type, 2020-2032, (USD Bn)

5. Global Congestive Heart Failure Market, By Diagnosis, 2020-2032, (USD Bn)

6. Global Congestive Heart Failure Market, By Device Type, 2020-2032, (USD Bn)

7. Global Congestive Heart Failure Market, By Gender, 2020-2032, (USD Bn)

8. Global Congestive Heart Failure Market, By Age Group, 2020-2032, (USD Bn)

9. Global Congestive Heart Failure Market, By End User, 2020-2032, (USD Bn)

10. Global Congestive Heart Failure Market, By Region, 2020 - 2032, Value (USD Bn)

11. Competitive Landscape

12. Analyst Recommendations

13. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â